The central $11 target reflects a rounded arithmetic mean of current analyst price targets of approximately $10.73, based on roughly 18 analysts tracked by S&P Global. The range is extraordinarily wide — from $4 to $20 — which underscores how divided the Street remains. The prevailing rating is "Hold," with a minority of bulls offset by a growing cluster of sells.
Recent actions have leaned bearish. In October 2026, Barclays downgraded SMR to Underweight with a $5 target, Citigroup cut its target to $4 (Sell), Truist lowered its target to $8 (Hold), RBC Capital moved to $7 (Sector Perform), and B. Riley trimmed its target to $10 while keeping a Buy. UBS downgraded to Sell with a $6 target in September. On the optimistic side, Canaccord Genuity and Cantor Fitzgerald have maintained Buy/Overweight ratings with targets near $15–$20, arguing the company's technology and pipeline justify a premium.
The reasoning behind the split is consistent: bulls emphasize NuScale's status as the only U.S. company with regulatory design approval for a small modular reactor and the transformative 6 GW ENTRA1–TVA project, while bears point to minimal revenue, heavy cash burn, and dilution. None of these figures is a guarantee of where shares will trade. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares closed near $5.62 in late October 2026, down roughly 64% year to date and not far above the 52-week low near $5.20 — a sharp contrast with the 52-week high of $45.54. To reach $11, the stock would need to rise approximately 96%, a very large move by any standard.
The path would require a decisive shift in the fundamental narrative. NuScale currently generates little revenue and posts consistent net losses; the investment case rests on converting a non-binding pipeline into firm, revenue-generating orders. Management has said it hopes to sign a power-purchase agreement (PPA) with TVA for the ENTRA1-backed project, which would represent the clearest catalyst for a re-rating. Absent such a milestone, the stock's negative earnings and reliance on future contracts make sustained appreciation difficult to justify on current fundamentals alone.
The technical picture remains defensive. SMR trades below its 50-day moving average (near $8.40) and its 200-day moving average (near $9.75), and it sits only a few percent above its 52-week low near $5.20. That $5.20 area is the key support level to monitor; a decisive break would open room toward new lows. On the upside, the stock faces psychological resistance around $10 and then the mean target near $11, with the wide analyst range ($4–$20) suggesting limited agreement on a durable ceiling. A sustained recovery would first require reclaiming the moving averages before any larger trend shift.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms vary. The most consequential near-term items include the next quarterly earnings report, any update on the ENTRA1–TVA PPA, further Doosan manufacturing milestones, and the pace of cash burn and ATM issuance. Investors should also watch analyst revisions, the status of legal inquiries, interest-rate moves, and any shift in sentiment toward long-duration nuclear names. None of these should be read as a forecast of a specific outcome or timing. From what I see, tracking these catalysts closely helps clarify the setup.
Beyond traditional analyst research, I rely on AI Daily Buy/Sell Signals to continuously monitor thousands of stocks and ETFs. This tool generates Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a name like SMR, it helps flag momentum shifts more efficiently than manual screening alone, which I find useful when weighing the wide analyst range and upcoming catalysts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for SMR turned positive on October 28, 2026. Looking at past instances where SMR's MACD turned positive, the stock continued to rise in 37 of 42 cases over the following month. The odds of a continued upward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SMR's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 63 cases where SMR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
SMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for SMR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.119) is normal, around the industry mean (4.038). P/E Ratio (-2.555) is within average values for comparable stocks, (37.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (208.333) is also within normal values, averaging (186.943).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. SMR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialMachinery